SCHEMBL7983994

SCHEMBL7983994

CC(=O)/C(=C/c1cccc(Cl)c1Cl)C(=O)OC(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.42
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
ALDH1A1 P00352 3/20 0.38
LMNA P02545 2/20 0.38
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA7 P43166 2/20 0.37
CA4 P22748 1/20 0.37
PTGS2 P35354 1/20 0.36
CA12 O43570 1/20 0.34
CA9 Q16790 1/20 0.34
CA14 Q9ULX7 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984000 1.00 SMN1; SMN2 (0.42) SMN1; SMN2KMT2AMEN1L3MBTL1NPC1
SCHEMBL15026426 0.89 CA1 (0.46) SMN1; SMN2KMT2AMEN1ALDH1A1LMNA
SCHEMBL7281037 0.87 KMT2A (0.39) SMN1; SMN2KMT2AMEN1L3MBTL1NPC1
SCHEMBL7281040 0.87 KMT2A (0.39) SMN1; SMN2KMT2AMEN1L3MBTL1NPC1
SCHEMBL4539662 0.84 MAPT (0.46) SMN1; SMN2KMT2AMEN1L3MBTL1NPC1
SCHEMBL4539659 0.84 MAPT (0.46) SMN1; SMN2KMT2AMEN1L3MBTL1NPC1
SCHEMBL10387257 0.84 MAPT (0.46) SMN1; SMN2KMT2AMEN1L3MBTL1NPC1
SCHEMBL7322381 0.84 SMN1; SMN2 (0.38) SMN1; SMN2KMT2AMEN1L3MBTL1NPC1
SCHEMBL7322373 0.84 SMN1; SMN2 (0.38) SMN1; SMN2KMT2AMEN1L3MBTL1NPC1
SCHEMBL822823 0.83 KMT2A (0.47) SMN1; SMN2KMT2AMEN1L3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194428-B1 BRAIN DISORDERS; PSYCHOLOGICAL DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 2001-02-27 US disclosed
US-6121284-A SPECIFIED 1-(ALKYL OR CYCLOALKYL)-2-METHYL-3-(ALKOXYCARBONYL)-4-(SUBSTITUTED PYRIDYL OR ARYL)-5-OXO-1,4,5,6,7,8-HEXAHYDROQUINOLINE COMPOUNDS; TREATING SICKLE CELL ANEMIA, PSYCHOSES, DEPRESSION BAYER AKTIENGESELLSCHAFT (DE) 2000-09-19 US disclosed
US-4742069-A CALCIUM ANTAGONIST, ANTIANGINA, ANTIISCHEMIC, HYPOTENSIVE HOFFMANN-LA ROCHE INC. (US) 1988-05-03 US disclosed